Terms: = Liver cancer AND ERBB2, c-erb B2, 2064, P04626, ENSG00000141736, c-erbB2, HER-2/neu, HER2, TKR1, NEU, NGL, HER-2 AND Treatment
694 results:
1. [Chinese expert consensus on the management of clinical pathway and adverse events of trastuzumab deruxtecan (2024 edition)].
Trastuzumab Deruxtecan Clinical Management Pathway and Adverse Reaction Management Consensus Expert Group
Zhonghua Zhong Liu Za Zhi; 2024 Apr; 46(4):304-318. PubMed ID: 38644266
[TBL] [Abstract] [Full Text] [Related]
2. Assessment of the Clinical Value of Platelet-to-Lymphocyte Ratio in Patients with Hepatocellular Carcinoma.
Chen X; Mohammed AF; Li C
Clin Appl Thromb Hemost; 2024; 30():10760296231221535. PubMed ID: 38591958
[TBL] [Abstract] [Full Text] [Related]
3. Comparative Preclinical Evaluation of HYNIC-Modified Designed Ankyrin Repeat Proteins
Larkina M; Varvashenya R; Yuldasheva F; Plotnikov E; Bezverkhniaia E; Tretyakova M; Zelchan R; Schulga A; Konovalova E; Vorobyeva A; Belousov M; Orlova A; Tolmachev V; Deyev S
Mol Pharm; 2024 Apr; 21(4):1919-1932. PubMed ID: 38557163
[TBL] [Abstract] [Full Text] [Related]
4. Discussing the safety and effectiveness of transcatheter arterial embolization combined with intravenous chemotherapy in treating locally advanced breast cancer.
Zhang J; Zhang J; Niu X; Zhou Y; Guo Y; Wang Y; Shou F
Sci Rep; 2024 Mar; 14(1):6003. PubMed ID: 38472493
[TBL] [Abstract] [Full Text] [Related]
5. treatment patterns and clinical outcomes of chidamide combined with endocrine therapy in hormone receptor-positive, her2-negative metastatic breast cancer: A real-world multicenter study.
Li D; Jin Y; Lin M; Zeng C; Guo Q; Liu Y; Zhang J
Cancer Med; 2024 Feb; 13(4):e6762. PubMed ID: 38457252
[TBL] [Abstract] [Full Text] [Related]
6. Clinical Internal Dosimetry and Biodistribution of 177 Lu-DOTA-Trastuzumab in her2-Positive Metastatic and Locally Advanced Breast Carcinoma.
Narwadkar YS; Parghane RV; Sahu S; Lad S; Deep K; Wanage G; Suralkar T; Banerjee S; Gupta S; Basu S; Badwe RA
Clin Nucl Med; 2024 Apr; 49(4):e149-e155. PubMed ID: 38350067
[TBL] [Abstract] [Full Text] [Related]
7. PD-1 inhibitor combined with albumin paclitaxel and apatinib as second-line treatment for patients with metastatic gastric cancer: a single-center, single-arm, phase II study.
Gou M; Zhang Y; Wang Z; Qian N; Dai G
Invest New Drugs; 2024 Apr; 42(2):171-178. PubMed ID: 38347177
[TBL] [Abstract] [Full Text] [Related]
8. [A Case of Advanced Recurrent Rectal cancer Successfully Treated by Rechallenge Therapy with an Anti-Epidermal Growth Factor Receptor(EGFR)Drug].
Sakuma T; Shibutani M; Fukuoka T; Kasashima H; Nishiyama M; Fukui Y; Natsuki S; Nishiyama T; Maruo K; Miki Y; Yoshii M; Tamura T; Toyokawa T; Lee S; Maeda K
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1504-1506. PubMed ID: 38303322
[TBL] [Abstract] [Full Text] [Related]
9. [A Case of Postoperative Recurrence of Bilateral Breast cancer in Which Stable Disease Condition Was Achieved by Olaparib].
Terakawa H; Kawata C; Kurokawa Y; Ooe Y; Mohri R; Hirata M; Moriyama H; Kinoshita J; Kawashima H; Inaki N
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1414-1416. PubMed ID: 38303292
[TBL] [Abstract] [Full Text] [Related]
10. [A Case of liver Metastasis of Gastric cancer Successfully Treated with SOX plus Nivolumab].
Ueno M; Endo S; Hori M; Kageyama C; Iwamoto R; Kinoshita S; Kitagawa S; Mineta S; Kanesada K; Higashida M; Ito Y; Okada T; Yoshimatsu K; Fujiwara Y; Ueno T
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1813-1815. PubMed ID: 38303216
[TBL] [Abstract] [Full Text] [Related]
11. [A Case of Triple Negative Breast cancer with Successful Control of Recurrent Disease Activity for More than Ten Years].
Yabe N; Watanuki R; Harada Y; Kondo A; Yanagisawa T; Maeda H; Kishi M; Yoshikawa T; Osumi K; Kamiya N; Sotome K; Ishii Y; Jinno H; Ikeda T; Watanabe M
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1759-1761. PubMed ID: 38303198
[TBL] [Abstract] [Full Text] [Related]
12. [A Case of her2-Positive Advanced Breast cancer Who Was Able to Start and Continue Chemotherapy Despite liver Damage Due to Diffuse liver Metastasis].
Fujimoto T; Maeda N; Ioka T; Nagano H
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1739-1741. PubMed ID: 38303191
[TBL] [Abstract] [Full Text] [Related]
13. [A Case of Recurrent Gastric cancer with Long-Term Control via Two Resections and Multidisciplinary treatment Including Nivolumab].
Bungo M; Takeno A; Hirao M; Hamakawa T; Yamamoto M; Matsui Y; Tokuyama S; Toshiyama R; Kawai K; Takahashi Y; Sakai K; Doi T; Goto K; Kato T; Takami K
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1715-1717. PubMed ID: 38303183
[TBL] [Abstract] [Full Text] [Related]
14. [neuroendocrine Carcinoma of the Non-Ampullary Duodenum-A Case Report].
Tsukamoto T; Edagawa E; Togano S; Hori T; Tsujio G; Kunimoto T; Kaizaki R; Inoue T; Takatsuka S; Fukushima H
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1700-1702. PubMed ID: 38303178
[TBL] [Abstract] [Full Text] [Related]
15. [Cytopathological characteristics of SMARCA4-deficient thoracic undifferentiated tumors in serous effusion].
Wang WN; Liu XT; Liang YM
Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):143-148. PubMed ID: 38281781
[No Abstract] [Full Text] [Related]
16. The cardioprotective potential of sodium-glucose cotransporter 2-inhibitors in breast cancer therapy-related cardiac dysfunction - A systematic review.
Chong JH; Chang WT; Chan JJ; Tan TJY; Chan JWK; Wong M; Wong FY; Chuah CTH
Curr Probl Cardiol; 2024 Mar; 49(3):102372. PubMed ID: 38281354
[TBL] [Abstract] [Full Text] [Related]
17. TBACkp: her2 expression status classification network focusing on intrinsic subenvironmental characteristics of breast cancer liver metastases.
Yang K; Song J; Liu M; Xue L; Liu S; Yin X; Liu K
Comput Biol Med; 2024 Mar; 170():108002. PubMed ID: 38277921
[TBL] [
